| Literature DB >> 27092121 |
Kevin Egan1, Des Field1, Mary C Rea2, R Paul Ross3, Colin Hill4, Paul D Cotter2.
Abstract
Bacteriocins are ribosomally synthesized antimicrobial peptides produced by bacteria, which have the ability to kill or inhibit other bacteria. Many bacteriocins are produced by food grade lactic acid bacteria (LAB). Indeed, the prototypic bacteriocin, nisin, is produced by Lactococcus lactis, and is licensed in over 50 countries. With consumers becoming more concerned about the levels of chemical preservatives present in food, bacteriocins offer an alternative, more natural approach, while ensuring both food safety and product shelf life. Bacteriocins also show additive/synergistic effects when used in combination with other treatments, such as heating, high pressure, organic compounds, and as part of food packaging. These features are particularly attractive from the perspective of controlling sporeforming bacteria. Bacterial spores are common contaminants of food products, and their outgrowth may cause food spoilage or food-borne illness. They are of particular concern to the food industry due to their thermal and chemical resistance in their dormant state. However, when spores germinate they lose the majority of their resistance traits, making them susceptible to a variety of food processing treatments. Bacteriocins represent one potential treatment as they may inhibit spores in the post-germination/outgrowth phase of the spore cycle. Spore eradication and control in food is critical, as they are able to spoil and in certain cases compromise the safety of food by producing dangerous toxins. Thus, understanding the mechanisms by which bacteriocins exert their sporostatic/sporicidal activity against bacterial spores will ultimately facilitate their optimal use in food. This review will focus on the use of bacteriocins alone, or in combination with other innovative processing methods to control spores in food, the current knowledge and gaps therein with regard to bacteriocin-spore interactions and discuss future research approaches to enable spores to be more effectively targeted by bacteriocins in food settings.Entities:
Keywords: Bacillus; Clostridium; LAB; antimicrobial peptide; bacteriocin; food processing; spore
Year: 2016 PMID: 27092121 PMCID: PMC4824776 DOI: 10.3389/fmicb.2016.00461
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Figure 1Germination dependent inhibition of spore outgrowth by bacteriocins. Dormant spores may germinate after being activated by a variety of means; most commonly sub-lethal heat being used. Heat is believed to activate the dormant spores by making the germinant receptors (GR) more accessible to nutrient germinants. Once the GR-nutrient binding occurs, the spore is now committed to germination even if the germinant is removed. Stage 1 of germination consists of H+, K+, and Na+ ion release followed by Ca2+-DPA release. This release of Ca2+-DPA triggers stage II of germination where the cortex is degraded, allowing the germ cell wall to expand and take up water. At the end of stage II the spore core is hydrated and has expanded along with the cortex. This rise in water content signals the end of stage II of germination and the beginning of the outgrowth phase. At this point bacteriocins that are not active against dormant spores become active, inhibit outgrowth and reduce viable counts from the germinated spore population. This figure is adapted from Setlow (2014a).
Bacteriocins that are active against vegetative cells of Gram-positive spore-forming bacteria.
| Acidocin LCHV | IId | 1158.2 | Broad | Heat stable | 3–8 | Mkrtchyan et al., | ||
| Acidocin LF221A Acidocin LF221B | IIb | 3500-5000 | Broad | Heat stable | 2–9 | Bogovic-Matijasić et al., | ||
| Bac217 | IId | 7000 | Broad | Heat stable | 3–12 | Lozo et al., | ||
| BacC1 | ND | 10,000 | Broad | Heat stable | 2–6 | Goh and Philip, | ||
| Bacteriocin L-1077 | IIa | 3454 | Broad | ND | ND | Svetoch et al., | ||
| Bifidocin B | IIb | 4432.9 | Narrow | Heat stable | 2–10 | Yildirim and Johnson, | ||
| Bificin C6165 | ND | 3395.1 | Narrow | Moderate | 3.5–6.5 | Pei et al., | ||
| Brevicin 925A | IId | ND | Narrow | Heat resistant | ND | Wada et al., | ||
| Divergicin 750 | IId | 3447.7 | Broad | ND | ND | Holck et al., | ||
| Duranicin TW-49M | IId | 5227.8 | Narrow | Moderate | 2–10 | Hu et al., | ||
| Enterocin 7A/7B | IId | 7A 5200.8 | Broad | ND | ND | Liu et al., | ||
| Enterocin A | IIa | 3829 | Broad | Heat stable | 2–10 | Aymerich et al., | ||
| Enterocin AS-48 | IIc | 7140 | Broad | Heat stable | ND | Lucas et al., | ||
| Enterocin B | IId | 5463 | Broad | Heat stable | ND | Casaus et al., | ||
| Enterocin EJ97 | IId | 5340 | Broad | Heat stable | 2–9.5 | Gálvez et al., | ||
| Enterocin L50 | IIb | A: 5190 | Broad | Heat stable | 2–11 | Cintas et al., | ||
| Enterocin IT | IId | 6390 | Narrow | ND | ND | Izquierdo et al., | ||
| Enterocin MR10 | IIb | A: 5201.6 | Broad | Heat stable | 4.6–9 | Martín-Platero et al., | ||
| Enterocin NKR-5-3B | IIc | 6316.42 | Broad | Heat stable | 2–10 | Himeno et al., | ||
| Enterocin RM6 | IId | 7145 | Broad | ND | ND | Huang et al., | ||
| Enterocin P | IId | 4493 | Broad | Heat stable | 2–11 | Cintas et al., | ||
| Enterocin SE-K4 | IIa | 5356.2 | Narrow | Heat stable | 3–11 | Eguchi et al., | ||
| Gassericin A | IIc | 3800 | Broad | Heat stable | 2–12 | Nakamura et al., | ||
| Gassericin KT7 | ND | ND | Broad | Heat stable | 2.5–9 | Zhu et al., | ||
| Garvieacin Q | IId | 5339 | Broad | Heat stable | 2–8 | Tosukhowong et al., | ||
| Lacticin 3147 | I | ltnA1: 3305 | Broad | Heat stable | 5–9 | McAuliffe et al., | ||
| Lacticin 481 | I | 2901 | Narrow | Heat stable | ND | Piard et al., | ||
| Lacticin LC14 | ND | 3333.7 | Broad | Heat stable | 2–10 | Lasta et al., | ||
| Lacticin Q | IId | 5926.5 | Broad | Heat stable | 2–10 | Fujita et al., | ||
| Lacticin Z | IId | 5968.9 | Broad | Heat stable | 2–10 | Iwatani et al., | ||
| Lactococcin BZ | ND | 5500 | Broad | Heat stable | 2–7 | Sahingil et al., | ||
| Lactococcin R | ND | 2500 | Broad | Heat stable | 2–9 | Yildirim and Johnson, | ||
| Leucocin H | IIb | ND | Broad | ND | ND | Blom et al., | ||
| Leucocyclicin Q | IIc | 6115.59 | Broad | ND | ND | Masuda et al., | ||
| Lactocyclin Q | IIc | 6062 | Broad | Heat stable | 3–9 | Sawa et al., | ||
| Mesentericin ST99 | ND | ND | Broad | Heat stable | 2–12 | Todorov and Dicks, | ||
| Macedocin | I | 2795 | Broad | Heat stable | 4–9 | Georgalaki et al., | ||
| Macedovicin | I | 3428.8 | Broad | ND | ND | Georgalaki et al., | ||
| Nisin | I | 3353.53 | Broad | Heat stable | 2–6 | Meghrous et al., | ||
| Nisin Z | I | 3330.93 | Broad | Heat stable | 2–6 | Rollema et al., | ||
| Nisin Q | I | 3327.5 | Broad | Heat stable | ND | Zendo et al., | ||
| Pediocin A | IIa | 80,000 | Broad | Heat sensitive | ND | Piva and Headon, | ||
| Pediocin AcH/PA-1 | IIa | 4624 | Broad | Heat stable | 2–10 | Marugg et al., | ||
| Pediocin AcM | IIa | 4618 | Broad | Heat stable | 1–12 | Elegado et al., | ||
| Pediocin L50 | IId | 5250 | Broad | Heat stable | 2–11 | Cintas et al., | ||
| Pentocin TV35b | ND | 3930 | Broad | Heat stable | 1–10 | Okkers et al., | ||
| Plantaricin 163 | IId | 3553.2 | Broad | Heat stable | 2–10 | Hu et al., | ||
| Plantaricin 423 | IIa | 3932 | Narrow | Heat stable | 1–10 | van Reenen et al., | ||
| Plantaricin C | Ì | 2880.3 | Broad | Heat stable | < 8 | Gonzalez et al., | ||
| Plantaricin KL-1Y | IId | 3497.97 | Broad | Heat stable | 2–12 | Rumjuankiat et al., | ||
| Plantaricin LP84 | ND | 1000 - 5000 | Broad | Heat stable | ND | Suma et al., | ||
| Plantaricin PZJ5 | IId | 2572.9 | Broad | Heat stable | 2–6 | Song et al., | ||
| Plantaricin S | IIb | α 2904 | Broad | Heat stable | 3–7 | Soliman et al., | ||
| Plantaricin ST31 | ND | 2755 | Broad | Heat stable | 3–8 | Todorov et al., | ||
| Plantaricin TF711 | ND | 2500 | Broad | Heat stable | 1–9 | Hernández et al., | ||
| Plantaracin UG1 | ND | 3000-10,000 | Narrow | Heat stable | 3.5–8 | Enan et al., | ||
| Plantaricin ZJ008 | ND | 1334.77 | Broad | Heat stable | 2–8 | Zhu et al., | ||
| Salivaricin D | I | 3467.55 | Broad | Heat stable | ND | Birri et al., | ||
| Thermophilin 1277 | I | 3700 | Broad | Heat stable | 3–10 | Kabuki et al., | ||
| Themophilin 13 | IIb | 5776 | Broad | ND | ND | Marciset et al., | ||
| Thermophilin T | ND | 2500 | Narrow | Heat stable | 1–12 | Aktypis et al., | ||
| VJ13B | IIa | 4000 | Broad | Moderate | 2–8 | Vidhyasagar and Jeevaratnam, | ||
| Weissellicin Y | IId | 4925 | Broad | Heat stable | 3–11 | Masuda et al., | ||
| Weissellicin M | IId | 4968 | Broad | Moderate | 3–11 | Masuda et al., |
Mass estimated using SDS-PAGE.
Mass calculated based on amino acid sequence.
Mass obtained using mass spectrometry.
ND, Not determined.
Bacteriocins that display inhibitory action against bacterial spores.
| Nisin | Komitopoulou et al., | |
| Enterocin AS-48 | Abriouel et al., | |
| Bificin C6165 | Pei et al., | |
| Lacticin 3147 | Martinez-Cuesta et al., | |
| Plantaricin TF711 | González and Zárate, | |
| Thurincin H | Wang et al., |
Bacteriocin mode of action against bacterial spores is heterogeneous.
| Nisin | None | None | Yes | Lipid II becomes available for nisin to bind following germination, followed by pore formation in the outgrowing spore. | Gut et al., | |
| Decreased rate | None | Yes | Aouadhi et al., | |||
| None | None | Yes | Mansour et al., | |||
| ND | None | Yes | Ramseier, | |||
| Increases rate | None | Yes | Mazzotta and Montville, | |||
| None | None | Yes | Nerandzic and Donskey, | |||
| None | None | Yes | Udompijitkul et al., | |||
| Enterocin AS-48 | ND | Sporicidal | No | Grande et al., | ||
| None | None | Yes | Abriouel et al., | |||
| ND | None | Yes | Lucas et al., | |||
| ND | None | Yes | Grande et al., | |||
| ND | None | Yes | Viedma et al., | |||
| Thurincin H | None | None | Yes | Wang et al., |
ND, Not determined.
Nisin addition to food reduces spore .
| 25 | Milk | 40 | Vessoni and Moraes, | ||
| 16 | |||||
| 46 | |||||
| 50 | Milk | 32 | Wandling et al., | ||
| 20 | |||||
| 42 | |||||
| 100 | Milk | 20 | Wandling et al., | ||
| 1.25 | Apple juice | 42 | Komitopoulou et al., |
RSM models can be used to predict a treatment to achieve a specific spore reduction in food.
| 5 Log10 spore/ml | 95 | 12 | 3.125 | Water | Aouadhi et al., | ||
| 5 Log10 spore/ml | 100 | 13 | 3.35 | Milk | |||
| 5 Log10 spore/ml | 100 | 15 | 3.375 | Chocolate milk | |||
| 5 Log10 spore/ml | 472 | 53 | 5 | 5.025 | Water | Aouadhi et al., | |
| 6 Log10 spore/ml | 654 | 74 | 13.6 | 8.2 | UHT milk | Gao et al., | |